CCDC114, DNAI2 and TOP2A involves in the effects of tibolone treatment on postmenopausal endometrium

Yanhua Lv1, Yanqing Liu2, Yueqiang Wang3

  • 1Department of Gynecology, Affiliated Hospital of Jining Medical University, Jining, 272000, Shandong, China.

BMC Women'S Health
|June 12, 2021
PubMed
Abstract

Insights

Tibolone treatment in postmenopausal women impacts gene expression, particularly affecting cilium movement and hormone regulation. TOP2A emerged as a key drug target in endometrial tissue.

Area of Science:

  • Genomics
  • Molecular Biology
  • Pharmacology

Background:

  • Tibolone is a synthetic steroid used in hormone therapy for postmenopausal women.
  • Understanding its molecular mechanisms is crucial for optimizing treatment efficacy and safety.
  • Endometrial changes are a key consideration in tibolone therapy.

Purpose of the Study:

  • To elucidate the molecular mechanisms of tibolone action in postmenopausal women.
  • To identify key genes and pathways affected by tibolone treatment in the endometrium.
  • To predict potential drug targets for tibolone therapy.

Main Methods:

  • Analysis of gene expression data (GSE12446) from tibolone-treated and control endometrial samples.
  • Identification of differentially expressed genes (DEGs) and enrichment analysis for biological processes and pathways.
  • Construction of protein-protein interaction (PPI) networks and prediction of drug-gene interactions.

Main Results:

  • Identified 238 up-regulated and 72 down-regulated DEGs.
  • DEGs enriched in pathways including cilium movement, calcium ion homeostasis, and hormone level regulation.
  • Discovered significant drug-gene interactions, with TOP2A and HTR2B being targeted by multiple drugs, and TOP2A targeted by 7 known drugs.

Conclusions:

  • CCDC114 and DNAI2 may be important in tibolone's effects via cilium movement.
  • TOP2A is identified as a potential crucial target of tibolone in the postmenopausal endometrium.
  • This study provides insights into tibolone's molecular targets and pathways.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.3K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
67.2K